Catch of the Week – Walgreens Pays Record $273 Million To Settle Three FCA Suits
Posted 01/25/19
Archive
Top Ten Healthcare Recoveries of 2018
Posted 01/15/19
-
- Amerisource Bergen Corporation - In...
When a Gift is Not a Gift: Pharma Companies Use Charities to Increase Drug Profits
Posted 12/13/18
Catch of the Week — Actelion Pharmaceticals
Posted 12/7/18
Healthcare Fraud: it’s not just Medicare and Medicaid
Posted 10/17/18
Catch of the Week – AmerisourceBergen Corporation
Posted 10/12/18
What Would You Do? Disgrace and Conflicts in Medical Clinical Studies
Posted 09/18/18
Third Circuit Clarifies the Public Disclosure Bar in United States ex rel. Silver v. PharMerica
Posted 09/7/18
Whistleblower Marc Silver secured a victory from the Third Circuit on September 4, 2018, which held that his action was not blocked by the “public disclosure bar” of the False Claims Act, reversing a lower court that had dismissed his action. The Third Circuit’s opinion appropriately recognizes that a whistleblower can use non-public information as a bridge between public information and allegations of fraud,...
AstraZeneca Settles Seroquel False Claims Action -- Again
Posted 08/9/18
How Copayment Waivers can Give Rise to a Whistleblower Claim
Posted 06/8/18
What’s not to like about a doctor waiving a patient’s copayment, or a pharmaceutical company offering a prescription drug assistance program? Turns out there are plenty of reasons to be concerned about such activities. And, as a recently announced $24 million settlement with Pfizer illustrates, unlawful patient cost waivers can result in big liability for defendants.
Patient cost-sharing is a core principle...